Recent Quotes (30 days)

You have no recent quotes
chg | %

Novadaq Technologies Inc.  

(Public, TSE:NDQ)   Watch this stock  
Find more results for NDQ
Sep 5 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 7.81 - 16.42
Open     -
Vol / Avg. 0.00/3,944.00
Mkt cap 831.73M
P/E     -
Div/yield     -
EPS -1.18
Shares 57.82M
Beta 0.40
Inst. own     -
Oct 26, 2017
Q3 2017 Novadaq Technologies Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Aug 11, 2017
Q2 2017 Novadaq Technologies Inc Earnings Release - Tentative
Aug 4, 2017
Novadaq Technologies Inc Extraordinary Shareholders Meeting

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -60.09% -66.08%
Operating margin -81.64% -67.94%
EBITD margin - -57.85%
Return on average assets -38.26% -33.82%
Return on average equity -52.44% -41.51%
Employees 416 -
CDP Score - -


5090 Explorer Dr Suite 202
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links


NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.